USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet 3i, Llc

USPTO PatentsView assignee record - 100 granted patents across 24 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE).

100
Total patents granted
24
CPC technology areas
19.1
Avg claims per patent
-8%
5-year filing velocity

The verdict

Biomet holds 100 US patents across 24 technology areas, rank #3,650 of 50,000 tracked assignees.

#3,650
of 50,000 US assignees by volume
Top 15%
by Innovation Score (49.4/100)
19.1
avg claims per patent
-8%
filing velocity, last 5 yrs

Portfolio overview

Biomet 3i, Llc has been granted 100 US utility patents between 2015 and 2025, placing Biomet 3i, Llc at rank #3,650 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE). As a US Corporation, Biomet 3i, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Biomet sits between Zimmer Spine, Inc. (101 patents, rank #3,646) and Forescout Technologies, Inc. (100 patents, rank #3,654) - the closest US assignees by grant volume. The composite Innovation Score of 49.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 48 grants, compared with 52 in the 2015–2019 window, a -8% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Biomet 3i, Llc's 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Biomet 3i, Llc against peers pursuing similar technology classes.

Who files at Biomet's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biomet holds 100 patents at rank #3,650, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biomet

By rank, the assignees closest to #3,650 in granted patent volume.

Leaders in A61C (Dentistry)

Other assignees with the most granted patents in Biomet's primary technology class.

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 8
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biomet 3i, Llc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 16 16.0%
2016 3 3.0%
2017 13 13.0%
2018 9 9.0%
2019 11 11.0%
2020 5 5.0%
2021 14 14.0%
2022 8 8.0%
2023 5 5.0%
2024 8 8.0%
2025 8 8.0%

Which technologies does Biomet 3i, Llc patent most?

Top 15 of 24 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#3,650

Across all tracked assignees

Innovation Score

49.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Biomet 3i, Llc hold?
Biomet 3i, Llc holds 100 US granted patents filed between 2015 and 2025, spanning 24 technology areas.
What is Biomet 3i, Llc's Innovation Score?
Biomet 3i, Llc has an Innovation Score of 49.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Biomet 3i, Llc focus on?
Biomet 3i, Llc's top technology area is A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE) with 99 patents. The company has filed patents in 24 CPC subclasses total.
Is Biomet 3i, Llc's patent filing rate increasing or decreasing?
Biomet 3i, Llc's recent filing velocity is -8% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Biomet 3i, Llc's patents?
Biomet 3i, Llc's patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Biomet 3i, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Biomet's 100 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Biomet ranks #3,650 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61C - see who else leads that technology area. A61C leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.